LivaNova PLC (LIVN) Position Reduced by Waverton Investment Management Ltd
Waverton Investment Management Ltd lowered its position in LivaNova PLC (NASDAQ:LIVN) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 109,220 shares of the company’s stock after selling 2,800 shares during the period. LivaNova comprises approximately 0.5% of Waverton Investment Management Ltd’s holdings, making the stock its 26th largest position. Waverton Investment Management Ltd’s holdings in LivaNova were worth $8,729,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the stock. PNC Financial Services Group Inc. increased its holdings in LivaNova by 9.8% in the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after buying an additional 153 shares in the last quarter. Riverhead Capital Management LLC increased its holdings in LivaNova by 76.3% in the second quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock valued at $108,000 after buying an additional 763 shares in the last quarter. Shelton Capital Management purchased a new position in LivaNova in the third quarter valued at about $209,000. Martingale Asset Management L P purchased a new position in LivaNova in the second quarter valued at about $221,000. Finally, Capstone Investment Advisors Netherlands B.V. purchased a new position in LivaNova in the second quarter valued at about $228,000. Hedge funds and other institutional investors own 86.00% of the company’s stock.
In other news, Director Hugh M. Morrison sold 1,830 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $88.00, for a total transaction of $161,040.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Alfred J. Novak sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $85.77, for a total transaction of $171,540.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,830 shares of company stock valued at $569,350. Company insiders own 0.28% of the company’s stock.
LivaNova (NASDAQ:LIVN) last posted its earnings results on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.76 by $0.17. The firm had revenue of $309.70 million during the quarter, compared to analyst estimates of $301.22 million. LivaNova had a net margin of 4.63% and a return on equity of 9.33%. LivaNova’s revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.78 EPS. research analysts anticipate that LivaNova PLC will post 3.24 earnings per share for the current year.
A number of brokerages have issued reports on LIVN. Zacks Investment Research raised shares of LivaNova from a “hold” rating to a “buy” rating and set a $89.00 target price for the company in a report on Thursday, November 9th. BTIG Research reissued a “hold” rating on shares of LivaNova in a research note on Tuesday, November 7th. Piper Jaffray Companies reissued a “buy” rating and set a $85.00 price objective on shares of LivaNova in a research note on Friday, November 3rd. Canaccord Genuity reissued a “hold” rating and set a $71.00 price objective on shares of LivaNova in a research note on Wednesday, September 20th. Finally, Jefferies Group raised their price objective on shares of LivaNova from $76.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, September 15th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company’s stock. LivaNova currently has an average rating of “Hold” and an average target price of $79.71.
COPYRIGHT VIOLATION NOTICE: “LivaNova PLC (LIVN) Position Reduced by Waverton Investment Management Ltd” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2018/01/10/livanova-plc-livn-position-reduced-by-waverton-investment-management-ltd.html.
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.